World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-4q45r2
Date of registration: 13/02/2012
Primary sponsor: Faculdade de Medicina de Botucatu - Brazil
Public title: Peripheral nerve blocks in patients undergoing shoulder surgery
Scientific title: A comparative study between interscalene brachial plexus block and selective suprascapular and axillary nerve block in arthroscopic shoulder surgery
Date of first enrolment: 15/06/2010
Target sample size: 68
Recruitment status: recruitment completed
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-4q45r2/
Study type: 
Study design:  Clinical trial, two-armed, randomized, open.  
Countries of recruitment
Brazil
Contacts
Name: Norma Sueli  Módolo
Address:  Distrito de Rubião Jr - Caixa Posta 530 18618-970 Botucatu Brazil
Telephone: 55 14 3811-6222
Email: nmodolo@fmb.unesp.br
Affiliation:  Faculdade de Medicina de Botucatu
Name: Norma Sueli  Módolo
Address:  Distrito de Rubião Jr - Caixa Posta 530 18618-970 Botucatu Brazil
Telephone: 55 14 3811-6222
Email: nmodolo@fmb.unesp.br
Affiliation:  Faculdade de Medicina de Botucatu
Key inclusion & exclusion criteria
Inclusion criteria: Candidates for arthroscopic shoulder surgery; aged between 18 and 80 years old; of either gender; of ASA physical status I or II; with a body mass index below 35 kg/m2; capable of understanding the visual analogue pain scale; and with no medical allergies
Exclusion criteria: Patients who do not accepted participate in the study

Age minimum: 18Y
Age maximum: 80Y
Gender: -
Health Condition(s) or Problem(s) studied
Arthroscopic Surgery
E01.370.388.250.070
M00-M99
Intervention(s)
Patients will be randomly assigned to two groups, with thirty people in each group:
GI - 30 patients undergoing interscalene blockade by Winnie with the aid of a peripheral nerve stimulator (Stimuplex, B. Braun, Melsungen, Germany) and A50 needle (B. Braun Melsunger) and 30ml of 0.375% bupivacaine are administered with vasoconstrictor.
G II - 30 patients who underwent blockade of suprascapular and axillary nerves, also with aid of a neurostimulator A100 and needle (B. Braun Melsunger).
The intervention was conducted in only one time during the surgery.
Primary Outcome(s)
Sensory block was assessed by loss of cold sensation in the area of innervation of nerves with their use of cotton soaked in ether. Motor block was evaluated by Bromage scale grade 1 = no blocking, grade 2 = unable to abduction and external rotation of the arm, grade 3 = complete block of every shoulder, arm and forearm).
Cardiovascular parameters (heart rate and systolic and diastolic blood pressures) were measured and recorded upon arrival in the operating room (T1), every 5 minutes after the blockade after 30 minutes after the start of surgery (T2), in the wake (T3) and on discharge from the recovery room (PACU) (T4). Cardiocirculatory instability (BP and HR> 30% of baseline pressure of patients) was also considered as a criterion for postoperative failure. Analgesia was measured by visual analog scale (O-no pain, 10 - worst possible pain) at times T0 (PACU), T6 (6 h after blocking) T12 (12 hours after the lock) and T24 (24 hours after the lock).

Secondary Outcome(s)
Cardiocirculatory parameters,incidence of nausea and vomiting, motor block discomfort
Secondary ID(s)
54/2010
Source(s) of Monetary Support
Hospital Santa Izabel - Brazil
Secondary Sponsor(s)
Faculdade de Medicina de Botucatu - Brazil
Hospital Santa Izabel - Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history